Evidence map›Paper›PMID 27548286›Full record

ArticlePLoS neglected tropical diseases2016

Ivermectin Treatment and Sanitation Effectively Reduce Strongyloides stercoralis Infection Risk in Rural Communities in Cambodia.

Armelle Forrer, Virak Khieu, Christian Schindler, Fabian Schär, Hanspeter Marti, Meng Chuor Char, Sinuon Muth, Peter Odermatt

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Tropical medicine and infectious disease · 2022
    Review
  6. The Association between Diabetes and Human T-Cell Leukaemia Virus Type-1 (HTLV-1) withInternational journal of environmental research and public health · 2022
    Article
  7. Article
  8. Seroprevalence of thePathogens (Basel, Switzerland) · 2020
    Article
  9. Progress towards the Control of Strongyloidiasis in Tropical Australia?The American journal of tropical medicine and hygiene · 2020
    Article
  10. Article
  11. The American journal of tropical medicine and hygiene · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Armelle ForrerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Virak KhieuNational Centre for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.
Christian SchindlerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Fabian SchärSwiss Tropical and Public Health Institute, Basel, Switzerland.
Hanspeter MartiSwiss Tropical and Public Health Institute, Basel, Switzerland.
Meng Chuor CharNational Centre for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.
Sinuon MuthNational Centre for Parasitology, Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.
Peter OdermattSwiss Tropical and Public Health Institute, Basel, Switzerland.
Ministry of Health · KHUniversity of Basel · CHSwiss Tropical and Public Health Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStrongyloides stercoralis is the only soil-transmitted helminth with the ability to replicate within its host, leading to long-lasting and potentially fatal infections. It is ubiquitous and its worldwide prevalence has recently been estimated to be at least half that of hookworm. Information on the epidemiology of S. stercoralis remains scarce and modalities for its large-scale control are yet to be determined. METHODOLOGY/PRINCIPAL

findingsA community-based two-year cohort study was conducted among the general population in a rural province in North Cambodia. At each survey, participants infected with S. stercoralis were treated with a single oral dose of ivermectin (200μg/kg BW). Diagnosis was performed using a combination of the Baermann method and Koga agar plate culture on two stool samples. The cohort included participants from eight villages who were either positive or negative for S. stercoralis at baseline. Mixed logistic regression models were employed to assess risk factors for S. stercoralis infection at baseline and re-infection at follow-up. A total of 3,096 participants were examined at baseline, revealing a S. stercoralis prevalence of 33.1%. Of these participants, 1,269 were followed-up over two years. Re-infection and infection rates among positive and negative participants at baseline were 14.4% and 9.6% at the first and 11.0% and 11.5% at the second follow-up, respectively. At follow-up, all age groups were at similar risk of acquiring an infection, while infection risk significantly decreased with increasing village sanitation coverage. CONCLUSIONS/SIGNIFICANCE: Chemotherapy-based control of S. stercoralis is feasible and highly beneficial, particularly in combination with improved sanitation. The impact of community-based ivermectin treatment on S. stercoralis was high, with over 85% of villagers remaining negative one year after treatment. The integration of S. stercoralis into existing STH control programs should be considered without further delay.

Indexed as

SanitationAdolescentAdultAnimalsAntinematodal AgentsCambodiaChildChild, PreschoolCohort StudiesCommunity MedicineFamily CharacteristicsFecesFemaleHumansIvermectinMaleAntinematodal AgentsIvermectin

Identifiers

PMID27548286
PMCPMC4993485
OpenAlexW2510076306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.